BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06099782-completion@plaintrial.com
DTSTAMP:20261028T163624Z
DTSTART;VALUE=DATE:20261116
SUMMARY:A Study of Participant Reported Preference for Subcutaneous Pembrol
 izumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenou
 s Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F1
 1) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06099782
URL:https://plaintrial.com/trial/NCT06099782
END:VEVENT
END:VCALENDAR